Could cause temporary or reversible harm; serious harm is unlikely.
Labeling: Label Mixup: ATORVASTATIN CALCIUM, Tablet, 20 mg may have potentially been mislabeled as one of the following drugs: COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: AD32325_4, EXP: 5/9/2014; ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: AD49582_7, EXP: 5/16/2014.
| Distributed by / for | AidaPak Service, LLC |
| NDC | 00378201777 |
| Full product label | ATORVASTATIN CALCIUM, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378201777. |
| Recalling firm | Aidapak Services, LLC |
| Distribution | Repacked drugs were distributed in Arizona, California, Oregon, and Washington. |
| Quantity | 811 Tablets |
| Recall initiated | 2013-07-02 |
| Report date | 2014-01-29 |
| Recall completed | 2014-02-07 |
| Recall number | D-901-2014 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Vancouver WA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗